The pages appear to be providing accurate, safe information. Watch out for ads on the sites that may advertise products frequently classified as a PUP Potentially Unwanted Products.
Thoroughly research any product advertised on the sites before you decide to download and install it. I just reached Microsoft support and they told me that Windows 7 product key will work, so I have to go to my office tomorrow to get the physical CD from 10 years ago. Hope that works. I see you mention that above, and previously I was told that only the Windows 10 key will work. So I'm happy there is a possible solution. I was able to retrieve my Windows 7 Home Premium license key but it fails to activate Windows Maybe because it's the Home edition and not the Pro?
I"m out of options it appears. Weird, since I updated to Win 10 from this Win 7 install. As I'm using a virtual machine on a Mac running the M1 chip my choices are limited. I only had one install option, as instructed by the Parallel VM faq, which was to download this file and use it to install Windows I can't figure out how to reach a human at Microsoft.
Even a chat would be ok. What is the story with Windows 11? After I upgraded, I found that I had to utilize a different version of Parallels and a pre-release version of Windows Once I had that installed and operating, from inside that system I tried to install Norton However, I received a warning "Norton cannot be installed on this operating system.
However, it can be installed on the following operating systems: Windows. I am trying to confirm 1 is that message correct or am I going about the install incorrectly I tried to install it from my account on Norton ; and 2 if correct, does Norton have plans to create a version of Norton compatible with Windows 11?
The issue I see is with the pre-release of Windows 11 which Norton parallels itself may not see as a supported OS. I am not looking to do that though. I also suspect that Norton is seeing Windows 11 as a not-supported OS.
Or will I have to wait until Norton has a release that fully supports Windows 11? Windows 11 is the issue in my view not Norton. Related maybe? I had previously tried to install Windows 10 but it would not install. I am not aware of any other way to run Parallels on my M1 Mac. With no solution being offered for my problem at this time, it appears my only option is to do without Norton and wait. When Windows 11 releases, Norton may have a version compatible that I can download.
If my Norton subscription expires before that happens, I will not renew. Jim is your Norton version 8. Also please keep in mind the M1 chip is ARM 64 based. Just an educated deduction on my part although I don't run MAC. I don't remember what version of Norton I was running in Parallels on my previous Mac. After that install, I went to my Norton account web page from a browser running in the virtual machine Parallels 17 and Windows 11 and attempted to download the latest version of Norton from there.
That is when I received the error message that it would not download because it was not compatible with the operating system Windows 11 I assume. From what little I have learned, in order to run Windows on an M1 Mac, I need to run Parallels 17 which has been designed to run on the M1 chip. Windows 10 will not install on Parallels 17, only Windows 11 will.
Parallels provides instructions on how to load and run Windows 11 on Parallels 17 on an M1 Mac. I have followed those instructions and so far everything works, including newer apps like Microsoft and some very old legacy apps dating back 10 years. So far, the only app I cannot get to work in this Windows 11 environment is Norton.
And, to be clear, the problem is that it will not download. It may in fact work once installed but I can't find out because it will not download. Have you attempted to and downloaded the Norton product installer to the host OS in a folder where you can access it from the VM, and ran that installer from inside the VM? Highlights The ultimate screen capture tool Enhance images with stamps, text, and effects Organize your screen captures with easy auto-storing and tagging features Share your images and videos to presentations, social media sites, and more.
Highlights Keep an eye on all network-enabled Apps running on your Mac Real-time monitoring so you can keep an eye on the exact state of your live network connections Provides a breakdown of per-app network usage, so you can quickly detect apps that are slowing down your network.
Be sure to check out our homepage for all the latest news, and follow 9to5Mac on Twitter , Facebook , and LinkedIn to stay in the loop. But lab experiments and epidemiological studies will be needed to fully appreciate the effects of these mutations.
How the Delta variant achieves its ultrafast spread. Evolving to evade immune responses such as antibodies could also carry some evolutionary costs.
There is clear evidence that some antibody-dodging mutations do not carry large evolutionary costs, says McLellan. To predict what these outbreaks will look like, scientists are investigating how quickly a population becomes newly susceptible to infection, says Kucharski, and whether that happens mostly though viral evolution, waning immune responses, or the birth of new children without immunity to the virus.
Infection or vaccination provides lifetime protection, and the virus circulates largely on the basis of new births. Most people get infected in their first two years of life. RSV is a leading cause of hospitalization of infants, but most childhood cases are mild.
Waning immunity and viral evolution together allow new strains of RSV to sweep across the planet each year, infecting adults in large numbers, but with mild symptoms thanks to childhood exposure. Influenza offers another scenario — in fact two. The influenza A virus, which drives global seasonal influenza epidemics each year, is characterized by the rapid evolution and spread of new variants able to escape the immunity elicited by past strains.
The result is seasonal epidemics, propelled largely by spread in adults, who can still develop severe symptoms. How quickly SARS-CoV-2 evolves in response to immunity will also determine whether — and how often — vaccines need to be updated.
The current offerings will probably need to be updated at some point, says Bedford. In a preprint 5 published in September, his team found signs that SARS-CoV-2 was evolving much faster than seasonal coronaviruses and even outpacing influenza A, whose major circulating form is called H3N2. Although other respiratory viruses, including seasonal coronaviruses such as E, offer several potential futures for SARS-CoV-2, the virus may go in a different direction entirely, say Rambaut and others.
The sky-high circulation of the Delta variant and the rise of Omicron — aided by inequitable vaccine roll-outs to lower-income countries and minimal control measures in some wealthy countries such as the United States and the United Kingdom — offer fertile ground for SARS-CoV-2 to take additional surprising evolutionary leaps. For instance, a document prepared by a UK government science advisory group in July raised the possibility that SARS-CoV-2 could become more severe or evade current vaccines by recombining with other coronaviruses.
Continued circulation in animal reservoirs, such as mink or white-tailed deer, brings more potential for surprising changes, such as immune escape or heightened severity. Vaccinating as many people as possible, while the jabs are still highly effective, could stop the virus from unlocking changes that drive a new wave.
These comparisons have been removed. Eguia, R. PLoS Pathog. PubMed Article Google Scholar. Volz, E. Cell , 64—75 Peacock, T. Liu, Y.
0コメント